A
BEAM icon

AlphaQuest’s Beam Therapeutics BEAM Stock Holding History

AlphaQuest’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,549
Closed -$791K – 243
2025
Q4 		$791K Sell
28,549
-2,111
-7% -$53.9K 0.04% 543
2025
Q3 		$744K Sell
30,660
-4,809
-14% -$95.7K 0.05% 564
2025
Q2 		$603K Buy
35,469
+27,207
+329% +$474K 0.06% 519
2025
Q1 		$161K Buy
8,262
+5,652
+217% +$148K 0.02% 1086
2024
Q4 		$64.7K Sell
2,610
-33,583
-93% -$857K 0.01% 1230
2024
Q3 		$887K Buy
36,193
+29,108
+411% +$752K 0.08% 402
2024
Q2 		$166K Buy
7,085
+2,132
+43% +$52.4K 0.02% 804
2024
Q1 		$164K Buy
+4,953
New +$154K 0.03% 704

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AlphaQuest's BEAM Position: Q1 2026 in Review

AlphaQuest sold out of Beam Therapeutics (BEAM) in Q1 2026, closing a stake of 28,549 shares — an estimated $791K sold.

AlphaQuest first reported a position in BEAM in Q1 2024 and held it in 8 quarters. The position peaked at $887K in Q3 2024. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • AlphaQuest reported no remaining Beam Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 28,549 Beam Therapeutics shares in Q1 2026, an estimated $791K.
  • AlphaQuest first reported a position in Beam Therapeutics in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Beam Therapeutics position peaked at $887K in Q3 2024.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.